FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like TGA Offers New Guidance on Electronic Instructions for Use September 6, 2018 HHS Gives Liability Cover for Coronavirus Countermeasures April 15, 2020 Malaysia Issues New Mandatory Device Reporting Requirements July 10, 2017